Detalhe da pesquisa
1.
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers.
J Viral Hepat
; 31(5): 221-232, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38545826